Lipid Emulsion, Intravenous — Competitive Intelligence Brief

Lipid Emulsion, Intravenous (Lipid Emulsion, Intravenous) competitive landscape: 4 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Parenteral nutrition supplement. Area: Nutrition support / Critical care.

marketed Parenteral nutrition supplement Nutrition support / Critical care Small molecule

Target snapshot

Lipid Emulsion, Intravenous (Lipid Emulsion, Intravenous) — Aya Sabry Mohamed Mohamed. Lipid emulsion provides essential fatty acids and calories intravenously by delivering a mixture of lipids in an emulsified form for parenteral nutrition.

Comparator set (4 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Lipid Emulsion, Intravenous TARGET	Lipid Emulsion, Intravenous	Aya Sabry Mohamed Mohamed	marketed	Parenteral nutrition supplement
SMOFlipid + Omegaven	SMOFlipid + Omegaven	General University Hospital, Prague	marketed	Lipid emulsion / Parenteral nutrition supplement
Lipid Emulsions, Intravenous	Lipid Emulsions, Intravenous	Stanley Dudrick's Memorial Hospital	marketed	Parenteral nutrition supplement
Lipofundin MCT 20%	Lipofundin MCT 20%	B. Braun Melsungen AG	marketed	Lipid emulsion; parenteral nutrition supplement
Amino acid solution	Amino acid solution	B.P. Koirala Institute of Health Sciences	marketed	Parenteral nutrition supplement

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Parenteral nutrition supplement class)

1. Aya Sabry Mohamed Mohamed · 1 drug in this class
2. B.P. Koirala Institute of Health Sciences · 1 drug in this class
3. Stanley Dudrick's Memorial Hospital · 1 drug in this class